Research & Markets: Alzheimer's Disease Product Profiles: immunotherapies can revolutionize treatment paradigm.

RESEARCH & Markets Ltd.; ALZHEIMER'S disease treatment; IMMUNOTHERAPY; PHARMACEUTICAL industry; DRUG efficacy; TREATMENT effectiveness

The article informs that Research & Markets Ltd. has announced the inclusion of the report "Product Profiles: Alzheimer's Disease: Immunotherapies can revolutionize treatment paradigm" to their offering. The report indicates that new drugs are expected to emerge that will increase chances for the treatment of Alzheimer's disease in the industry. It further shows that bapineuzumab and solanezumab have the potential to revolutionize Alzheimer's disease treatment.